Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Brain Neoplasms 3Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Stomach Neoplasms 1Seizures 1Prostatic Neoplasms 1Ovarian Neoplasms 1Ovarian Cysts 1Myofibroma 1Liver Neoplasms 1Hematologic Diseases 1Endobronchial Metastases 1Ear Neoplasms 1Cholecystitis 1Breast Neoplasms 1

Interventions

Saline Solution 2Propofol 2Stem Cell Transplantation 1Ropivacaine 1Remifentanil 1Morphine 1Mannitol 1Lidocaine 1Epinephrine 1Dexmedetomidine 1Dexamethasone 1Desflurane 1Bupivacaine 1Analgesics, Opioid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Supratentorial Neoplasms × Remifentanil × Clear all
NCT02593942 2015-11-02

Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy

Yeditepe University Hospital

Phase 4 Completed
80 enrolled

Supratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡